A Role for Glycine Transporter-2 Inhibitors in Regulating Accumbal Dopamine Levels and Voluntary Alcohol Intake in Rats

IF 2.7 Q2 SUBSTANCE ABUSE
Yasmin Olsson, Klara Danielsson, Ana Domi, Helga Lidö, Linda Engström Ruud, Mia Ericson, Bo Söderpalm
{"title":"A Role for Glycine Transporter-2 Inhibitors in Regulating Accumbal Dopamine Levels and Voluntary Alcohol Intake in Rats","authors":"Yasmin Olsson,&nbsp;Klara Danielsson,&nbsp;Ana Domi,&nbsp;Helga Lidö,&nbsp;Linda Engström Ruud,&nbsp;Mia Ericson,&nbsp;Bo Söderpalm","doi":"10.1111/acer.70418","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Glycinergic neurotransmission has been suggested as a tentative pharmacological treatment target for Alcohol Use Disorder (AUD), a devastating brain disease with limited treatment options that involves reduced dopamine (DA) activity in the nucleus Accumbens (nAc) and loss of control of alcohol intake. Glycine receptors (GlyRs) in the nAc, a pivotal part of the brain reward circuitry, are involved in regulating basal and alcohol-induced accumbal DA levels as well as voluntary alcohol intake in rats.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study in rats examined if inhibition of the glycine transporter 2 (GlyT-2, SLC6A5), present within glycinergic synapses, alters (1) accumbal DA and glycine content as measured by in vivo microdialysis coupled to HPLC and (2) the alcohol deprivation effect (ADE) in a two-bottle-choice alcohol consumption paradigm. Finally, (3) the presence of GlyT2-expressing fibers and GlyRs in the nAc was examined by immunohistochemistry (IHC).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In brief, the two partial GlyT2-inhibitors N-Arachidonyl-Glycine (NAGly, 10 mg/kg i.p.) and Opiranserin (20 mg/kg i.p.), but not the full GlyT2-inhibitor Org 25543, slightly elevated accumbal DA levels, while no effects on extrasynaptic glycine levels were observed. The reversible GlyT1-inhibitor Bitopertin (10 mg/kg p.o.) produced a pronounced glycine and DA elevation but combined GlyT1- and GlyT2 inhibition did not yield any statistically significant additive effects. In the alcohol consumption study, NAGly abolished the ADE as compared to placebo treatment. Finally, histology confirmed the presence of GlyT2 and GlyR in the nAc, although with a higher signal for GlyT2 in, for example, septal and basal forebrain regions.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Overall, this study indicates that synaptic GlyRs are involved in regulating nAc DA levels and alcohol intake in rats, but probably to a lesser extent than extrasynaptic GlyRs. Further studies that specifically target GlyT2 in, for example, the nAc and septal regions and that utilize refined techniques for measuring synaptic glycine levels are warranted to better characterize the role of glycinergic innervation in the reward circuitry and for regulating alcohol intake.</p>\n </section>\n </div>","PeriodicalId":72145,"journal":{"name":"Alcohol (Hanover, York County, Pa.)","volume":"50 9","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13594685/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcohol (Hanover, York County, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/acer.70418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Glycinergic neurotransmission has been suggested as a tentative pharmacological treatment target for Alcohol Use Disorder (AUD), a devastating brain disease with limited treatment options that involves reduced dopamine (DA) activity in the nucleus Accumbens (nAc) and loss of control of alcohol intake. Glycine receptors (GlyRs) in the nAc, a pivotal part of the brain reward circuitry, are involved in regulating basal and alcohol-induced accumbal DA levels as well as voluntary alcohol intake in rats.

Methods

This study in rats examined if inhibition of the glycine transporter 2 (GlyT-2, SLC6A5), present within glycinergic synapses, alters (1) accumbal DA and glycine content as measured by in vivo microdialysis coupled to HPLC and (2) the alcohol deprivation effect (ADE) in a two-bottle-choice alcohol consumption paradigm. Finally, (3) the presence of GlyT2-expressing fibers and GlyRs in the nAc was examined by immunohistochemistry (IHC).

Results

In brief, the two partial GlyT2-inhibitors N-Arachidonyl-Glycine (NAGly, 10 mg/kg i.p.) and Opiranserin (20 mg/kg i.p.), but not the full GlyT2-inhibitor Org 25543, slightly elevated accumbal DA levels, while no effects on extrasynaptic glycine levels were observed. The reversible GlyT1-inhibitor Bitopertin (10 mg/kg p.o.) produced a pronounced glycine and DA elevation but combined GlyT1- and GlyT2 inhibition did not yield any statistically significant additive effects. In the alcohol consumption study, NAGly abolished the ADE as compared to placebo treatment. Finally, histology confirmed the presence of GlyT2 and GlyR in the nAc, although with a higher signal for GlyT2 in, for example, septal and basal forebrain regions.

Conclusions

Overall, this study indicates that synaptic GlyRs are involved in regulating nAc DA levels and alcohol intake in rats, but probably to a lesser extent than extrasynaptic GlyRs. Further studies that specifically target GlyT2 in, for example, the nAc and septal regions and that utilize refined techniques for measuring synaptic glycine levels are warranted to better characterize the role of glycinergic innervation in the reward circuitry and for regulating alcohol intake.

甘氨酸转运蛋白-2抑制剂在调节大鼠伏隔多巴胺水平和自愿酒精摄入中的作用
背景:甘氨酸能神经传递已被认为是酒精使用障碍(AUD)的暂定药物治疗靶点,AUD是一种破坏性的脑部疾病,治疗方案有限,涉及伏隔核(nAc)多巴胺(DA)活性降低和酒精摄入失控。nAc中的甘氨酸受体(GlyRs)是大脑奖赏回路的关键部分,参与调节基础和酒精诱导的伏隔区DA水平以及大鼠的自愿酒精摄入。方法:本研究在大鼠中研究了甘氨酸突触中存在的甘氨酸转运蛋白2 (GlyT-2, SLC6A5)的抑制是否会改变(1)通过体内微透析结合高效液相色谱测量的accumbal DA和甘氨酸含量;(2)在两瓶选择酒精消费模式下的酒精剥夺效应(ADE)。最后,(3)通过免疫组化(IHC)检测nAc中glyt2表达纤维和GlyRs的存在。结果:简而言之,两种部分glyt2抑制剂N-Arachidonyl-Glycine (NAGly, 10 mg/kg i.p)和Opiranserin (20 mg/kg i.p),而不是完全glyt2抑制剂Org 25543,轻微升高伏隔区DA水平,而对突触外甘氨酸水平没有影响。可逆的GlyT1抑制剂Bitopertin (10mg /kg p.o)产生明显的甘氨酸和DA升高,但联合GlyT1和GlyT2抑制没有产生任何统计学上显著的附加效应。在酒精摄入研究中,与安慰剂治疗相比,NAGly消除了ADE。最后,组织学证实了GlyT2和GlyR在nAc中存在,尽管GlyT2在间隔区和基底前脑区具有更高的信号。结论:总的来说,本研究表明突触GlyRs参与调节大鼠nAc - DA水平和酒精摄入,但其程度可能低于突触外GlyRs。进一步的研究专门针对GlyT2,例如nAc和间隔区域,并利用精细的技术来测量突触甘氨酸水平,以更好地表征甘氨酸神经支配在奖励回路和调节酒精摄入中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书